We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Research Paper: Evaluation of the Anti-apoptotic and Anticytotoxic Effect of Epicatechin Gallate and Edaravone on SH-SY5Y Neuroblastoma Cells.
- Authors
Shokrzadeh, Mohammad; Javanmard, Hashem; Zadeh, Golpar Golmohammad; Emran, Hossein Asgarian; Modanlou, Mona; Yaghubi-Beklar, Saeed; Ataee, Ramin
- Abstract
Introduction: Parkinson disease (PD) is the second most common neurodegenerative disease affecting older individuals with signs of motor disability and cognitive impairment. Epicatechin (EC) and edaravone have neuroprotective effects most probably due to their antioxidant activity; however, a limited number of studies have considered their role in PD. This research aimed at investigating the neuroprotective effect of EC and edaravone in a neurotoxin-induced model of PD. Methods: An in vitro model of PD was made by subjecting SH-SY5Y neuroblastoma cells to neurotoxin: 6-hydroxydopamine (6-OHDA) 100 µM/well. The cytoprotective effect of EC and edaravone in five concentrations on cell viability was tested using the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) assay. The apoptotic assay was done by annexin V and propidium iodide method using flow cytometry. Results: According to the MTT assay analysis, EC and edaravone had protective effects against 6-OH DA-induced cytotoxicity in SH-SY5Y neuroblastoma cells that were much more significant for edaravone and also a relative synergistic effect between EC and edaravone was observed. The apoptotic analysis showed that edaravone alone could decrease early and late apoptosis, whereas EC diminished early apoptosis, but enhanced late apoptosis and necrosis. Besides, co-treatment of edaravone and EC had a synergistic effect on decreasing apoptosis and increasing cell viability. Conclusion: The protective effect of edaravone on apoptosis and cytotoxicity was demonstrated clearly and EC had a synergistic effect with edaravone.
- Subjects
EPICATECHIN; RESEARCH evaluation; COGNITION disorders; PROPIDIUM iodide; PARKINSON'S disease; NEUROBLASTOMA
- Publication
Basic & Clinical Neuroscience, 2019, Vol 10, Issue 6, p619
- ISSN
2008-126X
- Publication type
Academic Journal
- DOI
10.32598/bcn.9.10.1159.2